Related Experiment Video
Updated: Apr 18, 2026
09:30
Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform
Published on: August 17, 2022
3.7K
[Screening for genetic mutations in hyperphenylalaninemia using Ion Torrent PGM sequencing].
Yanyan Cao1, Yujin Qu, Fang Song
1Department of Medical Genetics, Capital Institute of Pediatrics, Beijing 100020, P. R. China.
Summary
This study developed a genetic screening method for hyperphenylalaninemia (HPA) using Ion Torrent PGM sequencing. The method accurately detects mutations for early HPA diagnosis and personalized treatment.
Area of Science:
- Genomics
- Molecular Diagnostics
- Biochemistry
Context:
- Hyperphenylalaninemia (HPA) is a metabolic disorder requiring early and accurate diagnosis.
- Current diagnostic methods may have limitations in comprehensive genetic screening.
- Genetic analysis is crucial for understanding the underlying causes of HPA.
Purpose:
- To establish a genetic screening method for HPA using Ion Torrent Personal Genome Machine (PGM).
- To enable early detection and differential diagnosis of hyperphenylalaninemia.
- To validate the method's accuracy in identifying known HPA-related gene mutations.
Summary:
- The study utilized Ion Ampliseq PCR and Ion Torrent PGM sequencing to analyze key HPA-related genes (PAH, GCH1, PTS, QDPR, PCBD1).
- The method was set up using samples from children with known HPA mutations and controls, then validated on ten HPA patients.
- Results demonstrated high read mapping accuracy and successful identification of known mutations, with validation against Sanger sequencing.
Impact:
- Ion Torrent PGM sequencing is a viable tool for screening genetic mutations causing HPA.
- The developed method supports individualized diagnosis and treatment strategies for HPA patients.
- This advancement contributes to improved clinical management of metabolic disorders.
